Anal fissure medical therapy

Revision as of 20:24, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Anal fissure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anal Fissure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Abdominal X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anal fissure medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anal fissure medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anal fissure medical therapy

CDC on Anal fissure medical therapy

Anal fissure medical therapy in the news

Blogs on Anal fissure medical therapy

Directions to Hospitals Treating Anal fissure

Risk calculators and risk factors for Anal fissure medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Most common cause of anal fissure is straining when constipated. For treatment of constipation, click here. Anal fissures in infants usually self-heal without anything more than frequently changing diapers and treating constipation if it is the cause. The topical therapy is the first line of treatment along with dietary and other conservative measures. Analgesia with lidocaine and vasodilators like nitroglycerin and nifedipine are chiefly used for the topical management. Botulinum toxin can be effective in 89% cases. It is reserved for the people who can't undergo surgery for high risk of incontinence.

Medical Therapy

  • For many years up until 1995, customary treatment included warm baths, topical anesthetics, stool bulking agents, mechanical anal stretching, and, sometimes, surgery. In 1995, doctors began using nitroglycerine cream (topical 1 percent isosorbide dinitrate) but found it less acceptable for long-term use due to patients developing a tolerance to the drug. In 1998, Italian researchers reported injecting botulinum toxin into the anal sphincter to promote healing by relieving anal spasm through relaxation of the muscle.

Symptomatic

  • Most anal fissures are shallow or superficial (less than a quarter of an inch or 0.64 cm deep). These fissures self-heal within a couple of weeks. Furthermore, the treatment used for hemorrhoid such as eating a high-fiber diet, using a stool softener, taking a painkiller and having a sitz bath can help.
  • Preferred regimen, sitz bath: anus to be immersed in warm water for 10-15 minutes q8-12h for 4 weeks.[1][2][3][4][5]

Pediatric

  • Anal fissures in infants usually self-heal without anything more than frequently changing diapers and treating constipation if it is the cause.

Chemical Sphincterotomy

  • Painful deep chronic fissures, will not heal because of poor blood supply caused by sphincter spasm. Traditionally, surgical operations were required which are both painful and associated with various long-term complications, particularly incontinence in a small proportion of cases.
  • Botulinum toxin injection, administered by colorectal surgeons, can also be used to relax the sphincter muscle and its use for this condition was first investigated in 1993.[6] Botulinum toxin can provide relief in 89% cases.[7] Combination of medical therapies may offer up to 98% cure rates.[8][3]
  • Botulinum toxin is reserved for the people who can't undergo surgery due to high risk for incontinence.[9][10]
  • Preferred regimen (1): Botulinum toxin type A (Botox) 10 Units (0.2 ml of 50 U/mL) intrasphincteric q30 days for 16 months.[11]

Topical medical therapy

The topical therapy is the first line of treatment along with dietary and other conservative measures.[12] Analgesia and vasodilators are chiefly used for the topical management.[4][13][14][15][16][17]

Topical analgesic

  • Preferred regimen: Lidocaine gel 2-5% to be applied locally as needed.

Topical vasodilators

  • Preferred regimen (1): Nitroglycerin 0.2 or 0.4% ointment to be applied rectally q12h for 8 weeks.[18][19][20]
  • Preferred regimen (2): Nifedipine 0.2-0.3% ointment to be applied topically q6-12h.[21][22]
  • Alternative regimen (1): Diltiazem 2% rectal gel q8h for 8 weeks.[23]
  • Alternative regimen (2): Bethanechol 0.1% rectal gel q8h for 8 weeks.

References

  1. Wald A, Bharucha AE, Cosman BC, Whitehead WE (2014). "ACG clinical guideline: management of benign anorectal disorders". Am. J. Gastroenterol. 109 (8): 1141–57, (Quiz) 1058. doi:10.1038/ajg.2014.190. PMID 25022811.
  2. Gupta P (2006). "Randomized, controlled study comparing sitz-bath and no-sitz-bath treatments in patients with acute anal fissures". ANZ J Surg. 76 (8): 718–21. doi:10.1111/j.1445-2197.2006.03838.x. PMID 16916391.
  3. 3.0 3.1 Nelson RL, Thomas K, Morgan J, Jones A (2012). "Non surgical therapy for anal fissure". Cochrane Database Syst Rev (2): CD003431. doi:10.1002/14651858.CD003431.pub3. PMID 22336789.
  4. 4.0 4.1 Jensen SL (1986). "Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran". Br Med J (Clin Res Ed). 292 (6529): 1167–9. PMC 1340178. PMID 3011180.
  5. Nelson R (2006). "Non surgical therapy for anal fissure". Cochrane database of systematic reviews (Online) (4): CD003431. PMID 17054170.
  6. Jost W, Schimrigk K (1993). "Use of botulinum toxin in anal fissure". Dis Colon Rectum. 36 (10): 974. PMID 8404394.
  7. Radwan MM, Ramdan K, Abu-Azab I, Abu-Zidan FM (2007). "Botulinum toxin treatment for anal fissure". Afr Health Sci. 7 (1): 14–7. doi:10.5555/afhs.2007.7.1.14. PMC 2366122. PMID 17604520.
  8. Tranqui P, Trottier D, Victor C, Freeman J (2006). "Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin" (PDF). Canadian journal of surgery. Journal canadien de chirurgie. 49 (1): 41–5. PMID 16524142.
  9. Jost WH (1997). "One hundred cases of anal fissure treated with botulin toxin: early and long-term results". Dis. Colon Rectum. 40 (9): 1029–32. PMID 9293930.
  10. Jost WH, Schrank B (1999). "Repeat botulin toxin injections in anal fissure: in patients with relapse and after insufficient effect of first treatment". Dig. Dis. Sci. 44 (8): 1588–9. PMID 10492136.
  11. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A (1998). "A comparison of botulinum toxin and saline for the treatment of chronic anal fissure". N. Engl. J. Med. 338 (4): 217–20. doi:10.1056/NEJM199801223380402. PMID 9435326.
  12. Haq Z, Rahman M, Chowdhury R, Baten M, Khatun M (2005). "Chemical sphincterotomy--first line of treatment for chronic anal fissure". Mymensingh Med J. 14 (1): 88–90. PMID 15695964.
  13. Davies D, Bailey J (2017). "Diagnosis and Management of Anorectal Disorders in the Primary Care Setting". Prim. Care. 44 (4): 709–720. doi:10.1016/j.pop.2017.07.012. PMID 29132530.
  14. Schlichtemeier S, Engel A (2016). "Anal fissure". Aust Prescr. 39 (1): 14–7. doi:10.18773/austprescr.2016.007. PMC 4816871. PMID 27041801.
  15. Carapeti EA, Kamm MA, Phillips RK (2000). "Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects". Dis. Colon Rectum. 43 (10): 1359–62. PMID 11052511.
  16. Knight JS, Birks M, Farouk R (2001). "Topical diltiazem ointment in the treatment of chronic anal fissure". Br J Surg. 88 (4): 553–6. doi:10.1046/j.1365-2168.2001.01736.x. PMID 11298624.
  17. Jonas M, Speake W, Scholefield JH (2002). "Diltiazem heals glyceryl trinitrate-resistant chronic anal fissures: a prospective study". Dis. Colon Rectum. 45 (8): 1091–5. PMID 12195195.
  18. Loder P, Kamm M, Nicholls R, Phillips R (1994). "'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate". Br J Surg. 81 (9): 1386–9. PMID 7953427.
  19. Watson S, Kamm M, Nicholls R, Phillips R (1996). "Topical glyceryl trinitrate in the treatment of chronic anal fissure". Br J Surg. 83 (6): 771–5. PMID 8696736.
  20. Simpson J, Lund J, Thompson R, Kapila L, Scholefield J (2003). "The use of glyceryl trinitrate (GTN) in the treatment of chronic anal fissure in children". Med Sci Monit. 9 (10): PI123–6. PMID 14523338.
  21. Antropoli C, Perrotti P, Rubino M, Martino A, De Stefano G, Migliore G, Antropoli M, Piazza P (1999). "Nifedipine for local use in conservative treatment of anal fissures: preliminary results of a multicenter study". Dis Colon Rectum. 42 (8): 1011–5. PMID 10458123.
  22. Katsinelos P, Kountouras J, Paroutoglou G, Beltsis A, Chatzimavroudis G, Zavos C, Katsinelos T, Papaziogas B (2006). "Aggressive treatment of acute anal fissure with 0.5% nifedipine ointment prevents its evolution to chronicity". World J Gastroenterol. 12 (38): 6203–6. PMID 17036396.
  23. Carapeti E, Kamm M, Phillips R (2000). "Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects". Dis. Colon Rectum. 43 (10): 1359–62. PMID 11052511.

​​ Template:WH Template:WS